A Case of Nonfatal Torsade de Pointes Associated With Psychiatric Polypharmacy

被引：2

作者：

Lister, Jonathan F. ^{[1
]}

Torbett, Amanda L. ^{[2
]}

Benge, Cassandra D. ^{[1
]}

Bean, Jennifer R. ^{[1
]}

机构：

[1] Vet Affairs Tennessee Valley Healthcare Syst, Dept Clin Pharm, Murfreesboro, TN 37129 USA

[2] Erlanger Med Ctr, Dept Clin Pharm, Chattanooga, TN USA

来源：

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2018年 / 38卷 / 02期

关键词：

QT INTERVAL PROLONGATION; MANAGEMENT;

D O I：

10.1097/JCP.0000000000000845

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：155 / 157

页数：3

共 6 条

[1]

Beach SR, 2013, PSYCHOSOMATICS, V54, P1, DOI 10.1016/j.psym.2012.11.001

[2] Clinical relevance and management of drug-related QT interval prolongation [J].

Crouch, MA ;

Limon, L ;

Cassano, AT .

PHARMACOTHERAPY, 2003, 23 (07) :881-908

[3] Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes [J].

Gupta, Akshay ;

Lawrence, Andrew T. ;

Krishnan, Kousik ;

Kavinsky, Clifford J. ;

Trohman, Richard G. .

AMERICAN HEART JOURNAL, 2007, 153 (06) :891-899

[4] Drug therapy: Drug-induced prolongation of the QT interval [J].

Roden, DM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1013-1022

[5] QT interval prolongation and the risk of torsades de pointes: essentials for clinicians [J].

Trinkley, Katy E. ;

Page, Robert Lee, II ;

Lien, Hoang ;

Yamanouye, Kevin ;

Tisdale, James E. .

CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (12) :1719-1726

[6] Induced QT prolongation and torsades de pointes [J].

Yap, YG ;

Camm, AJ .

HEART, 2003, 89 (11) :1363-1372

← 1 →